Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$546M |
| 2 |
Microsoft
MSFT
|
+$480M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$362M |
| 4 |
Meta Platforms (Facebook)
META
|
+$350M |
| 5 |
Coca-Cola
KO
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Robinhood
HOOD
|
+$1.04B |
| 2 |
Palantir
PLTR
|
+$800M |
| 3 |
Apple
AAPL
|
+$516M |
| 4 |
Netflix
NFLX
|
+$326M |
| 5 |
NVIDIA
NVDA
|
+$313M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.71% |
| 2 | Healthcare | 15.15% |
| 3 | Consumer Discretionary | 11.78% |
| 4 | Communication Services | 10.55% |
| 5 | Financials | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2801
Toro Corp
TORO
$152M
| $492K | ﹤0.01% |
156,600
+81,600
| +109% | +$233K |
2023 Q2
9 quarters
|
|
2802
Tao Synergies Inc
TAOX
$28.7M
| $492K | ﹤0.01% |
75,045
+54,045
| +257% | +$390K |
2025 Q2
1 quarter
|
|
2803
Pixelworks
PXLW
$35.9M
| $491K | ﹤0.01% |
44,762
+200
| +0.4% | +$1.9K |
2015 Q4
39 quarters
|
|
2804
Fidelity D&D Bancorp
FDBC
$318M
| $491K | ﹤0.01% |
11,191
+400
| +4% | +$17.6K |
2022 Q2
13 quarters
|
|
2805
AN2 Therapeutics
ANTX
$166M
| $490K | ﹤0.01% |
385,597
-13,257
| -3% | -$15.2K |
2024 Q2
5 quarters
|
|
2806
Plumas Bancorp
PLBC
$424M
| $488K | ﹤0.01% |
11,305
-5,795
| -34% | -$251K |
2022 Q4
11 quarters
|
|
2807
American Vanguard Corp
AVD
$47.2M
| $487K | ﹤0.01% |
84,900
+18,148
| +27% | +$86.5K |
2023 Q1
10 quarters
|
|
2808
Aquestive Therapeutics
AQST
$600M
| $486K | ﹤0.01% |
+87,000
| New | +$376K |
2025 Q3
0 quarters
|
|
2809
Contineum Therapeutics
CTNM
$503M
| $484K | ﹤0.01% |
41,200
+26,796
| +186% | +$216K |
2025 Q2
1 quarter
|
|
2810
OnKure Therapeutics
OKUR
$97.6M
| $483K | ﹤0.01% |
175,750
+53,114
| +43% | +$132K |
2022 Q2
13 quarters
|
|
2811
Virtus Investment Partners
VRTS
$869M
| $481K | ﹤0.01% |
2,529
-4,700
| -65% | -$925K |
2024 Q1
6 quarters
|
|
2812
Bristow Group
VTOL
$1.21B
| $479K | ﹤0.01% |
+13,273
| New | +$487K |
2025 Q3
0 quarters
|
|
2813
Bread Financial
BFH
$3.86B
| $476K | ﹤0.01% |
8,542
-12,100
| -59% | -$747K |
2025 Q2
1 quarter
|
|
2814
Apyx Medical
APYX
$109M
| $474K | ﹤0.01% |
221,697
+40,302
| +22% | +$85.3K |
2015 Q1
42 quarters
|
|
2815
Rocky Mountain Chocolate Factory
RMCF
$9.82M
| $474K | ﹤0.01% |
298,218
-3,929
| -1% | -$6.41K |
2013 Q2
49 quarters
|
|
2816
Century Casinos
CNTY
$24.1M
| $474K | ﹤0.01% |
181,649
+5,200
| +3% | +$13K |
2013 Q2
49 quarters
|
|
2817
Ocugen
OCGN
$324M
| $473K | ﹤0.01% |
+290,200
| New | +$322K |
2025 Q3
0 quarters
|
|
2818
Capital Group Dividend Growers ETF
CGDG
$5.66B
| $471K | ﹤0.01% |
+13,600
| New | +$463K |
2025 Q3
0 quarters
|
|
2819
Union Bankshares
UNB
$113M
| $471K | ﹤0.01% |
19,013
+1,855
| +11% | +$49.6K |
2017 Q2
33 quarters
|
|
2820
Geospace Technologies
GEOS
$60.5M
| $470K | ﹤0.01% |
24,800
-20,400
| -45% | -$330K |
2022 Q4
11 quarters
|
|
2821
XMAX Inc
XMAX
$567M
| $470K | ﹤0.01% |
85,300
+70,700
| +484% | +$210K |
2025 Q2
1 quarter
|
|
2822
SELLAS Life Sciences
SLS
$2.35B
| $470K | ﹤0.01% |
+291,822
| New | +$520K |
2025 Q3
0 quarters
|
|
2823
Auburn National Bancorp
AUBN
$92.5M
| $470K | ﹤0.01% |
16,509
| – | – |
2019 Q2
25 quarters
|
|
2824
Stifel
SF
$10.6B
| $467K | ﹤0.01% |
6,173
-89,100
| -94% | -$6.67M |
2024 Q2
5 quarters
|
|
2825
First Commonwealth Financial
FCF
$2.01B
| $465K | ﹤0.01% |
27,300
-32,600
| -54% | -$557K |
2024 Q4
3 quarters
|
|
Similar funds
Renaissance Technologies's Q3 2025 Portfolio in Review
As of Q3 2025, Renaissance Technologies held 4,038 positions worth $75.8B, up 0.77% from $75.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies withdrew a net $5.41B in Q3 2025, closing 581 positions and reducing 1,457 holdings. Its most notable exit was GE Aerospace, an estimated $235M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in Alphabet (Google) Class C worth $419M.
- Renaissance Technologies's largest Q3 2025 buy was Alphabet (Google) Class C: 1,720,002 shares worth $419M.
- Renaissance Technologies added most to Alphabet (Google) Class A in Q3 2025, an estimated $546M increase.
- Renaissance Technologies's biggest Q3 2025 reduction was Robinhood, cutting an estimated $1.04B.
- Renaissance Technologies fully exited GE Aerospace in Q3 2025, selling an estimated $235M.
- Renaissance Technologies's ten largest holdings make up 11% of its $75.8B portfolio in Q3 2025.
- Renaissance Technologies opened 515 new positions and closed 581 in Q3 2025.
- Renaissance Technologies's portfolio value rose 0.77% quarter-over-quarter to $75.8B.
Based on Renaissance Technologies's 13F filing for Q3 2025, filed 13 Nov 2025.